Carlene Baum

1.7k total citations
27 papers, 1.2k citations indexed

About

Carlene Baum is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Carlene Baum has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 7 papers in Pharmacology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Carlene Baum's work include Pharmaceutical industry and healthcare (7 papers), Pregnancy and Medication Impact (5 papers) and Pharmaceutical Economics and Policy (4 papers). Carlene Baum is often cited by papers focused on Pharmaceutical industry and healthcare (7 papers), Pregnancy and Medication Impact (5 papers) and Pharmaceutical Economics and Policy (4 papers). Carlene Baum collaborates with scholars based in United States, Sweden and Finland. Carlene Baum's co-authors include Dianne L. Kennedy, Andrew Baum, Jerome E. Singer, Joyce M. Piper, F W Rosa, Gerald A. Faich, Elina Hemminki, Sonja M. McKinlay, Robert S. Stern and Malissa Kay Shaw and has published in prestigious journals such as The Lancet, JAMA and Diabetes Care.

In The Last Decade

Carlene Baum

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlene Baum United States 15 257 193 186 169 158 27 1.2k
Gerald Haidinger Austria 27 225 0.9× 159 0.8× 274 1.5× 148 0.9× 105 0.7× 109 2.4k
J Bryant United Kingdom 20 253 1.0× 65 0.3× 140 0.8× 103 0.6× 89 0.6× 32 1.4k
Catherine Sass France 21 162 0.6× 233 1.2× 386 2.1× 146 0.9× 46 0.3× 61 1.7k
Susan M. Cohen United States 25 339 1.3× 128 0.7× 138 0.7× 374 2.2× 119 0.8× 90 2.2k
Alexandra Ward United States 21 92 0.4× 306 1.6× 308 1.7× 78 0.5× 109 0.7× 52 1.9k
Elizabeth Robinson New Zealand 25 450 1.8× 138 0.7× 563 3.0× 484 2.9× 67 0.4× 63 2.2k
Christina A. Mikosz United States 14 479 1.9× 123 0.6× 86 0.5× 160 0.9× 164 1.0× 30 1.6k
Joseph C. Gambone United States 25 426 1.7× 158 0.8× 301 1.6× 125 0.7× 81 0.5× 51 1.8k
Pekka Puska Finland 11 376 1.5× 73 0.4× 166 0.9× 117 0.7× 79 0.5× 19 1.1k
D L Wingard United States 20 374 1.5× 175 0.9× 368 2.0× 145 0.9× 27 0.2× 29 2.0k

Countries citing papers authored by Carlene Baum

Since Specialization
Citations

This map shows the geographic impact of Carlene Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlene Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlene Baum more than expected).

Fields of papers citing papers by Carlene Baum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlene Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlene Baum. The network helps show where Carlene Baum may publish in the future.

Co-authorship network of co-authors of Carlene Baum

This figure shows the co-authorship network connecting the top 25 collaborators of Carlene Baum. A scholar is included among the top collaborators of Carlene Baum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlene Baum. Carlene Baum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wysowski, Diane K., et al.. (1996). Sedative-hypnotic drugs and the risk of hip fracture. Journal of Clinical Epidemiology. 49(1). 111–113. 24 indexed citations
2.
Bergman, Ulf, et al.. (1993). Effects of exposure to benzodiazepine during fetal life. International Journal of Gynecology & Obstetrics. 41(2). 218–219. 4 indexed citations
3.
Bergman, Ulf, Franz W. Rosa, Carlene Baum, Bengt‐Erik Wiholm, & Gerald A. Faich. (1993). Effects of Exposure to Benzodiazepine During Fetal Life. Survey of Anesthesiology. 37(4). 195–195. 1 indexed citations
4.
Bergman, Ulf, et al.. (1992). Effects of exposure to benzodiazepine during fetal life. The Lancet. 340(8821). 694–696. 64 indexed citations
5.
Davis, Harold E., Carlene Baum, & David J. Graham. (1991). Indices of Drug Misuse for Prescription Drugs. International Journal of the Addictions. 26(7). 777–795. 8 indexed citations
6.
Piper, Joyce M., et al.. (1988). Maternal use of prescribed drugs associated with recognized fetal adverse drug reactions. American Journal of Obstetrics and Gynecology. 159(5). 1173–1177. 12 indexed citations
7.
Baum, Carlene, et al.. (1988). Prescription Drug Use in 1984 and Changes Over Time. Medical Care. 26(2). 105–114. 47 indexed citations
8.
Hemminki, Elina, et al.. (1988). Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86.. American Journal of Public Health. 78(11). 1479–1481. 110 indexed citations
9.
Kennedy, Dianne L., Joyce M. Piper, & Carlene Baum. (1988). Trends in Use of Oral Hypoglycemic Agents 1964–1986. Diabetes Care. 11(7). 558–562. 28 indexed citations
10.
Piper, Joyce M., Carlene Baum, & Dianne L. Kennedy. (1987). Prescription drug use before and during pregnancy in a Medicaid population. American Journal of Obstetrics and Gynecology. 157(1). 148–156. 66 indexed citations
11.
Faich, Gerald A., Julie B. Milstien, Charles Anello, & Carlene Baum. (1987). Sources of Spontaneous Adverse Drug Reaction Reports Received by Pharmaceutical Manufacturers. Drug Information Journal. 21(3). 251–255. 5 indexed citations
12.
Baum, Carlene. (1985). Drug Use and Expenditures in 1982. JAMA. 253(3). 382–382. 37 indexed citations
13.
Baum, Carlene, et al.. (1985). Noncontraceptive estrogens and progestins: use patterns over time.. PubMed. 65(3). 441–6. 105 indexed citations
14.
Baum, Carlene, et al.. (1985). Utilization of nonsteroidal antiinflammatory drugs. Arthritis & Rheumatism. 28(6). 686–692. 161 indexed citations
15.
Baum, Carlene. (1984). Drug Use in the United States in 1981. JAMA. 251(10). 1293–1293. 94 indexed citations
16.
Stern, Robert S., et al.. (1984). Isotretinoin and pregnancy. Journal of the American Academy of Dermatology. 10(5). 851–854. 83 indexed citations
17.
Kennedy, Dianne L., et al.. (1983). Antibiotic use in U.S. Hospitals in 1981. American Journal of Health-System Pharmacy. 40(5). 797–801. 12 indexed citations
18.
Baum, Carlene, et al.. (1983). Patient Drug Profiles and Medical Records as Sources of Hospital Drug-Use Information. American Journal of Health-System Pharmacy. 40(12). 2191–2193. 4 indexed citations
19.
Baum, Andrew, et al.. (1980). Psychological stress for alternatives of decontamination of TMI-2 reactor building atmosphere. Technical report. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 1 indexed citations
20.
Baum, Carlene, et al.. (1980). Changes in Attitudes towards Drug Educators as a Function of Communicator Sex and Role. Journal of Drug Education. 10(3). 249–256. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026